Related Experiment Video
Updated: Jul 28, 2026
09:29
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
[Depressive disorders in panic attack patients and their correction with escitalopram]
Likars'Ka Sprava
|January 7, 2006
Summary
This study found that most patients with panic attacks (PA) also experience depression. Escitalopram effectively treated depression and reduced PA, suggesting a common underlying mechanism like serotonin dysfunction.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Panic attacks (PA) frequently co-occur with depressive disorders.
- Understanding the specific depressive symptoms in PA patients is crucial for effective treatment.
Purpose of the Study:
- To investigate the specificity of depression in patients with panic attacks.
- To evaluate the efficacy and tolerability of escitalopram in treating depression and panic attacks.
Main Methods:
- A cohort of 33 patients with panic attacks (PA) was assessed for depression using the Beck Depression Inventory (BDI).
- Patients received escitalopram 10 mg/day for 2 months.
- Clinical peculiarities of depression and their association with PA characteristics were analyzed.
Main Results:
- Depression was diagnosed in 96.4% of PA patients, characterized by asthenia, somatic preoccupation, anxiety, and mood disturbances.
- Depression severity correlated significantly with PA duration and frequency.
- Escitalopram demonstrated high efficacy in treating depression, preventing PA, and was well-tolerated with mild side effects.
Conclusions:
- The high comorbidity of depression and PA suggests shared pathophysiological mechanisms, potentially involving serotonin dysfunction.
- Escitalopram is an effective treatment option for comorbid depression and panic attacks.
- Further research into the neurobiological underpinnings of this comorbidity is warranted.
Related Concept Videos
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:27Panic Disorder
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...